QT
TCRT icon

Quantbot Technologies’s Alaunos Therapeutics TCRT Stock Holding History

Quantbot Technologies’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-329
Closed -$177K – 1855
2021
Q1 		$177K Buy
+329
New +$205K 0.02% 748
2020
Q3 		– Sell
-15
Closed -$7K – 1634
2020
Q2 		$7K Buy
+15
New +$6.69K ﹤0.01% 972
2016
Q2 		– Sell
-49
Closed -$54K – 1340
2016
Q1 		$54K Buy
49
+9
+23% +$9.21K 0.01% 857
2015
Q4 		$50K Sell
40
-109
-73% -$180K 0.01% 795
2015
Q3 		$201K Buy
149
+134
+893% +$221K 0.04% 527
2015
Q2 		$26K Sell
15
-77
-84% -$120K ﹤0.01% 913
2015
Q1 		$148K Buy
+92
New +$136K 0.04% 494

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Quantbot Technologies's TCRT Position: Q2 2021 in Review

Quantbot Technologies sold out of Alaunos Therapeutics (TCRT) in Q2 2021, closing a stake of 329 shares — an estimated $177K sold.

Quantbot Technologies first reported a position in TCRT in Q1 2015 and held it in 7 quarters. The position peaked at $201K in Q3 2015. 155 funds tracked by Wall St. Rank hold TCRT as of Q2 2021.

  • Quantbot Technologies reported no remaining Alaunos Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Quantbot Technologies sold 329 Alaunos Therapeutics shares in Q2 2021, an estimated $177K.
  • Quantbot Technologies first reported a position in Alaunos Therapeutics in Q1 2015 and held it in 7 quarters.
  • Quantbot Technologies's Alaunos Therapeutics position peaked at $201K in Q3 2015.
  • 155 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2021.

Based on Quantbot Technologies's 13F filing for Q2 2021, filed 12 Aug 2021.